INTERNATIONAL PATENT: CELEX ONCOLOGY INNOVATIONS LIMITED FILES APPLICATION FOR "RANOLAZINE ENANTIOMER FOR USE IN CANCER TREATMENT"

GENEVA, Dec. 15 -- CELEX ONCOLOGY INNOVATIONS LIMITED (101 New Cavendish StreetLondon W1W 6XH) filed a patent application (PCT/EP2025/065580) for "RANOLAZINE ENANTIOMER FOR USE IN CANCER TREATMENT" on Jun 04, 2025. With publication no. WO/2025/252860, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FALTUM, Carsten (c/o Celex Oncology Innovations Limited101 New Cavendish StreetLondon W1W 6XH)

Abstract: The present disclosure relates to non-racemic compositions of ranolazine and enantiomerically pure formulations and pharm...